SP+’s Nicole Hankins Receives First Women in Parking Impact Award
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) — SP Plus Corporation (SP+), (Nasdaq: SP), a leading provider of technology-driven mobility solutions […]
TSX News -
Northview Apartment REIT Announces New Time for 2019 Third Quarter Webcast & Conference Call
CALGARY, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) — Northview Apartment Real Estate Investment Trust (“Northview”) (NVU.UN – TSX) announced today […]
Saturn Oil & Gas Confirms Commencement of Q4 2019 Drilling Program
CALGARY, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) — Saturn Oil & Gas Inc. (“Saturn” or the “Company”) (TSXV: SOIL) (FSE: […]
Second Supplemental LOI and Corporate Update
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) […]
First Commonwealth Announces Third Quarter 2019 Earnings; Declares Quarterly Dividend
INDIANA, Pa., Oct. 29, 2019 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) today announced financial results for the […]
Stelmine completes a private placement of $907,380
QUÉBEC, Québec, Oct. 29, 2019 (GLOBE NEWSWIRE) — Stelmine Canada Ltd. (“Stelmine”) (TSX-V: STH) announces today that it has completed […]
SMTC Corporation to Report Third Quarter Results on November 11, 2019
TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) — SMTC Corporation (Nasdaq:SMTX), a global electronics manufacturing services provider and winner of Frost […]
Methode Electronics to Present at the Baird 2019 Global Industrial Conference
CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application […]
Alimera Sciences Announces Third Quarter 2019 Financial Results and Provides Corporate Update
Third Quarter and Recent Company Highlights:Consolidated Net Revenue Up 16% Compared to Third Quarter 2018International Net Revenue Up 62% Compared […]
Y-mAbs Announces Proposed Public Offering of Common Stock
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical […]
